MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617072757 A) filed by Mindset Pharma Inc. on June 11, 2026, for Indole Derivatives As Serotonergic Agents Useful For The Treatment Of Disorders Related Thereto.
Inventor includes Slassi, Abdelmalik.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present disclosure relates to indole derivatives of general Formula (I), to processes for their preparation, to compositions including indole derivatives of general Formula (I), and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders, or conditions by activation of a serotonin receptors in a cell. The diseases, disorders, or conditions include, for example, psychosis, mental illnesses and CNS disorders.
Disclaimer: Curated by HT Syndication.
